Delirium is a common condition associated with patient morbidity and mortality.1 Exogenous steroids and pituitary or adrenal dysfunction can cause hypercortisolism (which can lead to Cushing syndrome), and are potential triggers for delirium.2,3 Family physicians are often the first point of contact for patients; therefore, recognizing the diverse physical, cognitive, and psychiatric signs and symptoms of hypercortisolism is important to prevent diagnostic and treatment delays.
Case
An 81-year-old female patient was admitted to hospital with a 1-month history of cognitive and functional decline, bizarre behaviour, hyperglycemia, worsening leg edema, and elbow cellulitis that was being treated with an antibiotic. Her medical history was notable for myelodysplastic syndrome, immunoglobulin G4-related disease, diabetes mellitus, hypertension, dyslipidemia, leg edema, and osteoporosis. Initial blood work was significant for leukocytosis (25.8×109/L; normal range 4 to 11×109/L), hypokalemia (2.7 mmol/L; normal range 3.5 to 5 mmol/L), hyperglycemia (21.8 mmol/L; normal range 3.3 to 11 mmol/L), and elevated hemoglobin A1c test result (12.9% average blood sugar level over the past 2 to 3 months; normal range 4.3% to 5.9%). C-reactive protein, calcium, renal function, and brain natriuretic peptide levels, and other test results for infection were unremarkable.
The patient’s family reported mild cognitive decline over the past year; however, the patient was functionally independent, aside from driving (self-terminated) and administering insulin doses. A month before hospital admission, the patient experienced acute cognitive decline, exhibiting bizarre behaviour (unable to pack for a trip, slowed responses, ordering 2 entrees at a restaurant, day-night reversal). While hospitalized, her cognition and behaviour deteriorated and were in keeping with delirium. The patient began singing, praying, chanting repeatedly, and resisting care. She was overinclusive and experienced fluctuations in mood and alertness. Blood test results for thyroid issues, vitamin B12 level, human immunodeficiency virus, and syphilis were unremarkable. Neuroimaging revealed findings of mild microangiopathic changes. The patient’s symptoms initially responded to risperidone, but the medication was discontinued due to somnolence. The suspected underlying causes of the patient’s delirium, including elbow cellulitis, hyperglycemia, constipation, and cystitis (developed during hospital admission), were treated and her delirium improved, but did not resolve.
The patient’s hospital stay was further complicated when she developed a bleeding gastric ulcer. Due to worsening abdominal pain, a computed tomography scan of her abdomen was performed. It revealed a 6.6 cm by 4.9 cm by 7.5 cm heterogeneous mass arising from the right adrenal gland.
Hormonal evaluation revealed suppressed adrenocorticotropic (ACTH) hormone level (1.1 pmol/L; normal range 1.6 to 13.9 pmol/L), and elevated morning blood cortisol level (867 nmol/L; normal range 120 to 620 nmol/L), testosterone level (6.1 nmol/L; normal <2 nmol/L), 24-hour urine cortisol level (2664 nmol/day; normal <160 nmol/day), and late-night salivary cortisol level (27.4 nmol/L; normal <2.8 nmol/L). Dehydroepiandrosterone sulfate level was high normal (4.0 μmol/L; normal range 0.3 to 4.2 μmol/L). Serum metanephrine and normetanephrine levels were normal. These findings, along with a positron emission tomography scan that showed an intensely hypermetabolic right adrenal mass, supported a diagnosis of adrenal cortical carcinoma causing severe Cushing syndrome.
Given the patient’s comorbidities and the size of the adrenal lesion, the patient was not a candidate for surgical removal. Therefore, the patient was treated medically with ketoconazole to normalize her urinary cortisol level; her 24-hour urine cortisol level subsequently decreased from 2664 nmol/day to 427 nmol/day. She was also concurrently treated for leg cellulitis that developed during her hospital stay; however, it was believed the leg cellulitis was unrelated to her prolonged delirium. As the patient’s cortisol level decreased, her acute medical issues stabilized, including leukocytosis, edema, hypokalemia, abdominal pain, bleeding in the gastrointestinal tract, and diabetes. The patient’s cognition and behaviour also improved substantially, although she did not recover to her previous baseline.
Discussion
Cushing syndrome refers to the constellation of signs and symptoms that result from chronic hypercortisolism, regardless of the underlying cause.3 The most common cause of hypercortisolism is exogenous glucocorticoid therapy; endogenous cortisol overproduction is much less frequent.3 Endogenous Cushing syndrome is categorized as either ACTH-dependent (approximately 80% of cases) or ACTH-independent (approximately 20% of cases).3,4 ACTH-dependent causes include Cushing disease (pituitary adenoma secreting ACTH) and, less commonly, ectopic ACTH secretion from non-pituitary tumours or ectopic corticotropin-releasing hormone secreting tumours.3,4 ACTH-independent causes most often involve adrenal adenomas; other rare causes include adrenal carcinomas, macronodular adrenal hyperplasia, and primary pigmented nodular adrenocortical disease.4
Patients with Cushing syndrome usually present with clinical features of varying severity including obesity, facial plethora, dorsocervical fat pad, ecchymoses, red and purple striae (stretch marks) greater than 1 cm in width, thin skin, poor skin healing, abdominal pain, proximal muscle weakness, hirsutism, lethargy, and edema.3,5 Coexisting conditions may include hypertension, abnormal glucose tolerance, hypokalemia, reduced bone density, dyslipidemia, and infections.3,5,6 Given many of these signs and symptoms are present in other, more common diseases, diagnosis of Cushing syndrome is often delayed.7 Signs and symptoms potentially related to Cushing syndrome in the patient in the above-described case included thin skin, abdominal pain, osteoporosis, and infections, as well as hypokalemia, hyperglycemia, and worsening edema that were resistant to standard therapy.
Cognitive or psychiatric changes that may present with Cushing syndrome are varied and can include depression, irritability, cognitive or memory deficits, changes to personality, anxiety, labile emotions, hyperphagia, hypersomnia or insomnia, posttraumatic stress disorder, and vivid dreams.3-5,8,9 Mania and psychosis are also possible, but rare.8 The hippocampus, amygdala, and frontal cortex of the brain were found to be particularly affected by glucocorticoid excess6 and therefore patients often present with multidomain cognitive deficits.4 The patient in the case above presented with cognitive changes, labile emotions, hyperphagia, and symptoms consistent with mania. Katragadda and colleagues found that a higher level of serum cortisol and longer duration of uncontrolled Cushing syndrome were associated with greater cognitive impairment.10 Therefore, timely diagnosis and treatment of Cushing syndrome is important to maximize a patient’s chance of cognitive recovery.
Initial diagnostic investigation of Cushing syndrome involves confirming hypercortisolism and establishing the underlying cause.3 Screening tests for hypercortisolism include 24-hour urinary free cortisol, late-night salivary cortisol, and 1-mg overnight dexamethasone suppression tests.3 Ideally, 2 or more of these tests should be done to diagnose hypercortisolism.3 Once hypercortisolism is confirmed, a plasma ACTH test is required to help distinguish between ACTH-dependent and ACTH-independent causes.3 Further localization requires additional imaging, such as magnetic resonance imaging of the pituitary gland or computed tomography of the adrenal gland.3
Treatment of endogenous Cushing syndrome aims to address the underlying cause of glucocorticoid excess, usually by surgically removing a tumour.3,6 In cases where surgery is not feasible or fails to achieve remission, medical therapy can be used.6 Options include steroidogenesis inhibitors, glucocorticoid receptor antagonists, and drugs targeting ACTH production.3 Radiation therapy may also be needed in some cases.3 Long-term follow-up is essential, as patients are at risk for adrenal insufficiency requiring glucocorticoid replacement and disease recurrence.3 The patient in the above case was not a candidate for surgery and was therefore treated with a steroidogenesis inhibitor (ketoconazole).
Reflecting on the case of the patient described above, we found her psychiatric and cognitive symptoms to be the most prominent and interesting. Her initial presentation was felt to be most in keeping with delirium secondary to uncontrolled diabetes, cellulitis, constipation, and urinary tract infection. After treating these conditions, the patient improved but not as quickly, or as much as expected, suggesting another contributing etiology. This additional etiology was found inadvertently when a computed tomography scan of the patient’s abdomen was ordered due to pain and ultimately revealed an adrenal mass.
Conclusion
It is challenging to make a diagnosis of Cushing syndrome given its varied presentation and the fact many signs and symptoms are also present in other conditions.7 While screening for Cushing syndrome should not be part of routine delirium investigation given its rarity, it should be considered if delirium is persistent and not responding to treatment as expected, especially if other features of hypercortisolism are present.
Notes
Editor’s key points
▸ Cushing syndrome results from chronic glucocorticoid excess that manifests as physical, cognitive, and psychiatric signs and symptoms.
▸ Consider screening for Cushing syndrome in patients with persistent delirium and clinical features of hypercortisolism.
▸ Endogenous causes of Cushing syndrome are rare; adrenocorticotropic hormone (ACTH)-independent causes most often involve adrenal adenomas.
▸ Consider pharmacotherapy such as steroidogenesis inhibitors, glucocorticoid receptor antagonists or medications targeting ACTH production, or radiation therapy when surgical removal of a tumour is not possible.
Points de repère du rédacteur
▸ Le syndrome de Cushing résulte d’un excès chronique de glucocorticoïdes qui se manifeste par des symptômes physiques, cognitifs et psychiatriques.
▸ Envisagez un dépistage du syndrome de Cushing chez les patients souffrant d’un delirium persistent et ayant les caractéristiques cliniques d’un hypercortisolisme.
▸ Les causes endogènes du syndrome de Cushing sont rares; les causes indépendantes de l’adrénocorticotrophine (ACTH) impliquent le plus souvent des adénomes surrénaliens.
▸ Envisagez une pharmacothérapie comme des inhibiteurs de la stéroïdogenèse, des antagonistes du récepteur des glucocorticoïdes, des médicaments ciblant la production de l’ACTH ou encore une radiothérapie si l’ablation chirurgicale d’une tumeur n’est pas possible.
Footnotes
Competing interests
None declared
This article has been peer reviewed.
- Copyright © 2025 the College of Family Physicians of Canada






